On June 17, 2026, a new publication involving tesamorelin, a growth hormone-releasing hormone, appeared in the journal eNeurologicalSci. The publication is titled "The effect of growth hormone-releasing hormone on cognition and brain connectivity in adults with cognition ranging from normal to mild cognitive impairment." This entry is indexed under PubMed ID 42382101. The publication is listed as a new addition to the scientific literature concerning tesamorelin. No results, outcomes, or conclusions from the study are included in this brief beyond the title and publication details provided. Readers interested in the full scope of the research, including any methodology or findings, are encouraged to consult the original source directly. Tesamorelin remains an approved compound, and this publication represents an addition to the body of research associated with it. For further background on tesamorelin, including its approved uses and general profile, readers can refer to the compound overview.
Tesamorelin Study Published on Cognition, Brain Connectivity
See the full tesamorelin overview
Source: https://pubmed.ncbi.nlm.nih.gov/42382101/